Insider Trading › MRK › Insiders
Merck & Co., Inc.
MRK·NYSE·
United States·Insider activity
United States·Insider activity$142.79
+0.85 (+0.60%)
Close · Oct 7, 2026 · Close Prices from Tiingo.com
MRK
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
MRKS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, MRK insiders filed 0 purchases ($0) and 17 sales ($30.0M) on the open market, by 5 insiders. Newest filing Aug 13, 2026 (1 month ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by MRK insiders · Form 4 · last two years
On Record
$0Purchases · 180 days
$30.0MSales · 180 days
520Open-market transactions on record
5Insiders filing · 180 days
Purchases (code P) and sales (code S) of MRK common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
520 on record · newest trade first · the newest 300 shown
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Guindo ChirfiEVP, Access, Policy & Comms | Sale | −10.0K | $135.00 | $1.4M | 36.6Kdirect | Aug 13, 2026 | Aug 13, 2026 | Form 4 ↗ |
| Zachary JenniferEVP, General Counsel | Sale | −80.3K | $133.46 | $10.7M | 45.5Kdirect | Aug 12, 2026 | Aug 13, 2026 | Form 4 ↗ |
| DeLuca Richard R.EVP&Pres, Merck Animal Heallth | Sale | −600 | $132.04 | $79K | 110.2Kdirect | Aug 12, 2026 | Aug 12, 2026 | Form 4 ↗ |
| DeLuca Richard R.EVP&Pres, Merck Animal Heallth | Sale | −11.1K | $131.61 | $1.5M | 110.8Kdirect | Aug 12, 2026 | Aug 12, 2026 | Form 4 ↗ |
| DeLuca Richard R.EVP&Pres, Merck Animal Heallth | Sale | −7,410 | $131.33 | $973K | 127.3Kdirect | Aug 11, 2026 | Aug 12, 2026 | Form 4 ↗ |
| DeLuca Richard R.EVP&Pres, Merck Animal Heallth | Sale | −5,427 | $132.35 | $718K | 121.9Kdirect | Aug 11, 2026 | Aug 12, 2026 | Form 4 ↗ |
| DeLuca Richard R.EVP&Pres, Merck Animal Heallth | Sale | −20.8K | $130.43 | $2.7M | 134.7Kdirect | Aug 10, 2026 | Aug 12, 2026 | Form 4 ↗ |
| DeLuca Richard R.EVP&Pres, Merck Animal Heallth | Sale | −805 | $131.02 | $105K | 160.7Kdirect | Aug 6, 2026 | Aug 10, 2026 | Form 4 ↗ |
| DeLuca Richard R.EVP&Pres, Merck Animal Heallth | Sale | −4,945 | $130.23 | $644K | 155.8Kdirect | Aug 6, 2026 | Aug 10, 2026 | Form 4 ↗ |
| DeLuca Richard R.EVP&Pres, Merck Animal Heallth | Sale | −300 | $131.02 | $39K | 155.5Kdirect | Aug 6, 2026 | Aug 10, 2026 | Form 4 ↗ |
| Guindo ChirfiEVP, Access, Policy & Comms | Sale | −15.0K | $131.00 | $2.0M | 46.6Kdirect | Aug 6, 2026 | Aug 7, 2026 | Form 4 ↗ |
| Maraldo David R.EVP & Pres. MMD | Sale | −9,709 | $128.72 | $1.2M | 18.2Kdirect | Aug 5, 2026 | Aug 7, 2026 | Form 4 ↗ |
| Maraldo David R.EVP & Pres. MMD | Sale | −6,311 | $128.72 | $812K | 18.2Kdirect | Aug 5, 2026 | Aug 7, 2026 | Form 4 ↗ |
| Maraldo David R.EVP & Pres. MMD | Sale | −2,686 | $128.72 | $346K | 18.2Kdirect | Aug 5, 2026 | Aug 7, 2026 | Form 4 ↗ |
| Williams David MichaelEVP,Chief Info&Digital Officer | Sale | −4,600 | $128.77 | $592K | 31.7Kdirect | Aug 5, 2026 | Aug 7, 2026 | Form 4 ↗ |
| Williams David MichaelEVP,Chief Info&Digital Officer | Sale | −34.7K | $128.77 | $4.5M | 31.7Kdirect | Aug 5, 2026 | Aug 7, 2026 | Form 4 ↗ |
| Williams David MichaelEVP,Chief Info&Digital Officer | Sale | −13.5K | $128.77 | $1.7M | 31.7Kdirect | Aug 5, 2026 | Aug 7, 2026 | Form 4 ↗ |
| Guindo ChirfiChief Marketing Officer | Sale | −10.0K | $121.46 | $1.2M | 60.6Kdirect | Feb 12, 2026 | Feb 12, 2026 | Form 4 ↗ |
| Li Dean YExecutive VP & President, MRL | Sale | −10.2K | $117.52 | $1.2M | 92.0Kdirect | Feb 10, 2026 | Feb 10, 2026 | Form 4 ↗ |
| Guindo ChirfiChief Marketing Officer | Sale | −10.0K | $118.41 | $1.2M | 70.6Kdirect | Feb 9, 2026 | Feb 9, 2026 | Form 4 ↗ |
| Zachary JenniferEVP, General Counsel | Sale | −38.8K | $119.15 | $4.6M | 68.9Kdirect | Feb 9, 2026 | Feb 9, 2026 | Form 4 ↗ |
| Zachary JenniferEVP, General Counsel | Sale | −56.8K | $119.15 | $6.8M | 68.9Kdirect | Feb 9, 2026 | Feb 9, 2026 | Form 4 ↗ |
| Zachary JenniferEVP, General Counsel | Sale | −25.9K | $119.15 | $3.1M | 68.9Kdirect | Feb 9, 2026 | Feb 9, 2026 | Form 4 ↗ |
| Williams David MichaelEVP,Chief Info&Digital Officer | Sale | −5,000 | $121.91 | $610K | 30.8Kdirect | Feb 6, 2026 | Feb 6, 2026 | Form 4 ↗ |
| Oosthuizen Johannes JacobusPresident, U.S. Market | Sale | −15.0K | $121.87 | $1.8M | 21.2Kdirect | Feb 6, 2026 | Feb 6, 2026 | Form 4 ↗ |
| DeLuca Richard R.EVP&Pres, Merck Animal Heallth | Sale | −37.7K | $120.92 | $4.6M | 160.2Kdirect | Feb 6, 2026 | Feb 6, 2026 | Form 4 ↗ |
| Guindo ChirfiChief Marketing Officer | Sale | −20.0K | $121.88 | $2.4M | 80.6Kdirect | Feb 5, 2026 | Feb 6, 2026 | Form 4 ↗ |
| Smart Dalton E. IIISVP Fin. - Global Controller | Sale | −2,400 | $119.68 | $287K | 8,205direct | Feb 4, 2026 | Feb 6, 2026 | Form 4 ↗ |
| Smart Dalton E. IIISVP Fin. - Global Controller | Sale | −4,000 | $119.68 | $479K | 10.6Kdirect | Feb 4, 2026 | Feb 6, 2026 | Form 4 ↗ |
| Litchfield CarolineEVP & CFO | Sale | −42.0K | $119.61 | $5.0M | 90.2Kdirect | Feb 4, 2026 | Feb 6, 2026 | Form 4 ↗ |
| Li Dean YExecutive VP & President, MRL | Sale | −15.1K | $118.77 | $1.8M | 102.3Kdirect | Feb 4, 2026 | Feb 6, 2026 | Form 4 ↗ |
| Davis Robert MChairman, CEO & President · Director | Sale | −32.5K | $118.35 | $3.8M | 443.6Kdirect | Feb 4, 2026 | Feb 6, 2026 | Form 4 ↗ |
| Davis Robert MChairman, CEO & President · Director | Sale | −15.0K | $117.38 | $1.8M | 476.1Kdirect | Feb 4, 2026 | Feb 6, 2026 | Form 4 ↗ |
| Downing Cristal NChief Comm. & Public Afrs Ofcr | Sale | −7,085 | $87.00 | $616K | 0direct | Nov 10, 2025 | Nov 12, 2025 | Form 4 ↗ |
| Williams David MichaelEVP,Chief Info&Digital Officer | Sale | −8,614 | $83.59 | $720K | 24.6Kdirect | Nov 3, 2025 | Nov 4, 2025 | Form 4 ↗ |
| Smart Dalton E. IIISVP Fin. - Global Controller | Sale | −4,262 | $82.76 | $353K | 7,778direct | Apr 25, 2025 | Apr 29, 2025 | Form 4 ↗ |
| Oosthuizen Johannes JacobusPresident, U.S. Market | Sale | −8,500 | $84.09 | $715K | 30.7Kdirect | Feb 19, 2025 | Feb 20, 2025 | Form 4 ↗ |
| Williams David MichaelEVP,Chief Info&Digital Officer | Sale | −6,000 | $85.34 | $512K | 24.1Kdirect | Feb 13, 2025 | Feb 13, 2025 | Form 4 ↗ |
| THULIN INGE GDirector | Purchase | +2,833 | $88.25 | $250K | 2,933direct | Feb 6, 2025 | Feb 7, 2025 | Form 4 ↗ |
| Downing Cristal NChief Comm. & Public Afrs Ofcr | Sale | −2,361 | $88.76 | $210K | 7,085direct | Feb 6, 2025 | Feb 7, 2025 | Form 4 ↗ |
| BAKER DOUGLAS M JRDirector | Purchase | +15.0K | $88.50 | $1.3M | 16.0Kdirect | Feb 5, 2025 | Feb 7, 2025 | Form 4 ↗ |
| Litchfield CarolineEVP & CFO | Sale | −38.3K | $125.50 | $4.8M | 50.9Kdirect | Feb 14, 2024 | Feb 15, 2024 | Form 4 ↗ |
| Davis Robert MChairman, CEO & President · Director | Sale | −85.0K | $125.40 | $10.7M | 348.3Kdirect | Feb 14, 2024 | Feb 15, 2024 | Form 4 ↗ |
| Davis Robert MChairman, CEO & President · Director | Sale | −25.3K | $126.37 | $3.2M | 348.3Kdirect | Feb 13, 2024 | Feb 15, 2024 | Form 4 ↗ |
| Davis Robert MChairman, CEO & President · Director | Sale | −124.7K | $125.74 | $15.7M | 373.7Kdirect | Feb 13, 2024 | Feb 15, 2024 | Form 4 ↗ |
| Romanelli JosephPresident, Human Health Int?l | Sale | −1,000 | $124.89 | $125K | 19.6Kdirect | Feb 13, 2024 | Feb 14, 2024 | Form 4 ↗ |
| Li Dean YExecutive VP & President, MRL | Sale | −14.7K | $125.50 | $1.8M | 46.2Kdirect | Feb 9, 2024 | Feb 12, 2024 | Form 4 ↗ |
| Williams David MichaelEVP,Chief Info&Digital Officer | Sale | −1,451 | $127.57 | $185K | 19.8Kdirect | Feb 7, 2024 | Feb 8, 2024 | Form 4 ↗ |
| Oosthuizen Johannes JacobusPresident, U.S. Market | Sale | −19.0K | $127.18 | $2.4M | 23.3Kdirect | Feb 2, 2024 | Feb 5, 2024 | Form 4 ↗ |
| MIZELL STEVENEVP, Chief HR Officer | Sale | −50.7K | $126.65 | $6.4M | 23.6Kdirect | Feb 2, 2024 | Feb 2, 2024 | Form 4 ↗ |
| Zachary JenniferEVP, General Counsel | Sale | −49.5K | $126.97 | $6.3M | 29.1Kdirect | Feb 2, 2024 | Feb 2, 2024 | Form 4 ↗ |
| Oosthuizen Johannes JacobusPresident, U.S. Market | Sale | −2,081 | $102.38 | $213K | 18.2Kdirect | Nov 9, 2023 | Nov 13, 2023 | Form 4 ↗ |
| DeLuca Richard R.EVP&Pres, Merck Animal Heallth | Sale | −43.8K | $105.03 | $4.6M | 111.8Kdirect | Nov 8, 2023 | Nov 9, 2023 | Form 4 ↗ |
| MIZELL STEVENEVP, Chief HR Officer | Sale | −4,250 | $109.01 | $463K | 22.9Kdirect | Aug 14, 2023 | Aug 15, 2023 | Form 4 ↗ |
| MIZELL STEVENEVP, Chief HR Officer | Sale | −4,500 | $105.49 | $475K | 27.2Kdirect | Aug 3, 2023 | Aug 4, 2023 | Form 4 ↗ |
| Romanelli JosephPresident, Human Health Int?l | Sale | −59 | $107.37 | $6K | 0indirect | Aug 2, 2023 | Aug 3, 2023 | Form 4 ↗ |
| Romanelli JosephPresident, Human Health Int?l | Sale | −30 | $107.37 | $3K | 20.6Kdirect | Aug 2, 2023 | Aug 3, 2023 | Form 4 ↗ |
| Zachary JenniferEVP, General Counsel | Sale | −19.1K | $117.59 | $2.3M | 35.1Kdirect | May 4, 2023 | May 5, 2023 | Form 4 ↗ |
| Karachun Rita ASr. VP Fince-Global Controller | Sale | −15.9K | $117.53 | $1.9M | 45.7Kdirect | May 4, 2023 | May 5, 2023 | Form 4 ↗ |
| MIZELL STEVENEVP, Chief HR Officer | Sale | −13.4K | $119.01 | $1.6M | 31.7Kdirect | May 3, 2023 | May 5, 2023 | Form 4 ↗ |
| MIZELL STEVENEVP, Chief HR Officer | Sale | −12.0K | $119.01 | $1.4M | 33.1Kdirect | May 3, 2023 | May 5, 2023 | Form 4 ↗ |
| MIZELL STEVENEVP, Chief HR Officer | Sale | −15.0K | $119.01 | $1.8M | 45.1Kdirect | May 3, 2023 | May 5, 2023 | Form 4 ↗ |
| MIZELL STEVENEVP, Chief HR Officer | Sale | −13.0K | $119.01 | $1.5M | 60.1Kdirect | May 3, 2023 | May 5, 2023 | Form 4 ↗ |
| Williams David MichaelEVP,Chief Info&Digital Officer | Sale | −7,509 | $116.82 | $877K | 11.1Kdirect | May 2, 2023 | May 3, 2023 | Form 4 ↗ |
| DeLuca Richard R.EVP&Pres, Merck Animal Heallth | Sale | −75.4K | $116.03 | $8.8M | 154.5Kdirect | May 1, 2023 | May 2, 2023 | Form 4 ↗ |
| DeLuca Richard R.EVP&Pres, Merck Animal Heallth | Sale | −66.2K | $115.00 | $7.6M | 154.5Kdirect | Apr 28, 2023 | May 2, 2023 | Form 4 ↗ |
| Davis Robert MChairman, CEO & President · Director | Sale | −143.3K | $114.93 | $16.5M | 271.8Kdirect | Apr 28, 2023 | Apr 28, 2023 | Form 4 ↗ |
| Romanelli JosephPresident, Human Health Int?l | Purchase | +3 | $113.68 | $341 | 20.6Kdirect | Apr 26, 2023 | Jun 30, 2023 | Form 4 ↗ |
| Chattopadhyay SanatExe V-P & Pres. MMD | Sale | −67.9K | $115.07 | $7.8M | 0direct | Apr 13, 2023 | Apr 14, 2023 | Form 4 ↗ |
| Chattopadhyay SanatExe V-P & Pres. MMD | Sale | −66.2K | $115.06 | $7.6M | 67.9Kdirect | Apr 13, 2023 | Apr 14, 2023 | Form 4 ↗ |
| Romanelli JosephPresident, Human Health Int?l | Sale | −35 | $104.65 | $4K | 20.6Kdirect | Mar 24, 2023 | Jun 30, 2023 | Form 4 ↗ |
| Romanelli JosephPresident, Human Health Int?l | Purchase | +136 | $105.47 | $14K | 20.6Kdirect | Mar 20, 2023 | Jun 30, 2023 | Form 4 ↗ |
| Romanelli JosephPresident, Human Health Int?l | Purchase | +11 | $109.20 | $1K | 20.5Kdirect | Feb 21, 2023 | Jun 30, 2023 | Form 4 ↗ |
| Romanelli JosephPresident, Human Health Int?l | Sale | −5,000 | $108.22 | $541K | 20.3Kdirect | Feb 15, 2023 | Feb 16, 2023 | Form 4 ↗ |
| MIZELL STEVENEVP, Chief HR Officer | Sale | −1,815 | $109.10 | $198K | 33.1Kdirect | Feb 13, 2023 | Feb 14, 2023 | Form 4 ↗ |
| MIZELL STEVENEVP, Chief HR Officer | Sale | −5,000 | $107.00 | $535K | 34.9Kdirect | Feb 9, 2023 | Feb 10, 2023 | Form 4 ↗ |
| MIZELL STEVENEVP, Chief HR Officer | Sale | −4,436 | $104.25 | $462K | 39.9Kdirect | Feb 6, 2023 | Feb 8, 2023 | Form 4 ↗ |
| Zachary JenniferEVP, General Counsel | Sale | −75.4K | $103.17 | $7.8M | 53.9Kdirect | Feb 3, 2023 | Feb 6, 2023 | Form 4 ↗ |
| Chattopadhyay SanatExe V-P & Pres. MMD | Sale | −1,702 | $114.46 | $195K | 29.5Kdirect | Jan 9, 2023 | Jan 11, 2023 | Form 4 ↗ |
| Chattopadhyay SanatExe V-P & Pres. MMD | Sale | −38.2K | $113.78 | $4.3M | 31.2Kdirect | Jan 9, 2023 | Jan 11, 2023 | Form 4 ↗ |
| Chattopadhyay SanatExe V-P & Pres. MMD | Sale | −3,940 | $112.78 | $444K | 69.4Kdirect | Jan 9, 2023 | Jan 11, 2023 | Form 4 ↗ |
| Chattopadhyay SanatExe V-P & Pres. MMD | Sale | −4,538 | $111.73 | $507K | 73.4Kdirect | Jan 9, 2023 | Jan 11, 2023 | Form 4 ↗ |
| Chattopadhyay SanatExe V-P & Pres. MMD | Sale | −35.6K | $110.61 | $3.9M | 77.9Kdirect | Jan 9, 2023 | Jan 11, 2023 | Form 4 ↗ |
| Romanelli JosephPresident, Human Health Int?l | Purchase | +7 | $109.04 | $763 | 20.5Kdirect | Dec 19, 2022 | Jun 30, 2023 | Form 4 ↗ |
| Romanelli JosephPresident, Human Health Int?l | Purchase | +56 | $110.96 | $6K | 20.5Kdirect | Dec 13, 2022 | Jun 30, 2023 | Form 4 ↗ |
| Romanelli JosephPresident, Human Health Int?l | Purchase | +30 | $109.39 | $3K | 20.4Kdirect | Dec 6, 2022 | Jun 30, 2023 | Form 4 ↗ |
| Romanelli JosephPresident, Human Health Int?l | Purchase | +107 | $109.54 | $12K | 20.4Kdirect | Dec 5, 2022 | Jun 30, 2023 | Form 4 ↗ |
| Romanelli JosephPresident, Human Health Int?l | Purchase | +59 | $109.67 | $6K | 59indirect | Dec 2, 2022 | Jun 30, 2023 | Form 4 ↗ |
| MIZELL STEVENEVP, Chief HR Officer | Sale | −15.0K | $101.42 | $1.5M | 32.1Kdirect | Nov 10, 2022 | Nov 10, 2022 | Form 4 ↗ |
| Oosthuizen Johannes JacobusPresident, U.S. Market | Sale | −1,795 | $103.21 | $185K | 16.7Kdirect | Nov 9, 2022 | Nov 10, 2022 | Form 4 ↗ |
| Davis Robert MCEO & President · Director | Sale | −100 | $103.59 | $10K | 247.6Kdirect | Nov 9, 2022 | Nov 10, 2022 | Form 4 ↗ |
| Davis Robert MCEO & President · Director | Sale | −79.9K | $102.98 | $8.2M | 247.7Kdirect | Nov 9, 2022 | Nov 10, 2022 | Form 4 ↗ |
| Davis Robert MCEO & President · Director | Sale | −87.6K | $101.94 | $8.9M | 327.6Kdirect | Nov 9, 2022 | Nov 10, 2022 | Form 4 ↗ |
| MIZELL STEVENEVP, Chief HR Officer | Sale | −20.0K | $101.00 | $2.0M | 32.1Kdirect | Nov 8, 2022 | Nov 10, 2022 | Form 4 ↗ |
| FRAZIER KENNETH CExecutive Chair · Director | Sale | −84.7K | $100.07 | $8.5M | 700.7Kdirect | Nov 7, 2022 | Nov 8, 2022 | Form 4 ↗ |
| FRAZIER KENNETH CExecutive Chair · Director | Sale | −126.1K | $99.42 | $12.5M | 785.4Kdirect | Nov 7, 2022 | Nov 8, 2022 | Form 4 ↗ |
| FRAZIER KENNETH CExecutive Chair · Director | Sale | −24.9K | $98.45 | $2.5M | 911.5Kdirect | Nov 7, 2022 | Nov 8, 2022 | Form 4 ↗ |
| Oosthuizen Johannes JacobusPresident, U.S. Market | Sale | −45.6K | $99.47 | $4.5M | 18.5Kdirect | Nov 7, 2022 | Nov 7, 2022 | Form 4 ↗ |
| FRAZIER KENNETH CExecutive Chair · Director | Sale | −34.8K | $99.08 | $3.4M | 700.7Kdirect | Nov 4, 2022 | Nov 7, 2022 | Form 4 ↗ |
| FRAZIER KENNETH CExecutive Chair · Director | Sale | −200.2K | $98.53 | $19.7M | 735.5Kdirect | Nov 4, 2022 | Nov 7, 2022 | Form 4 ↗ |
| FRAZIER KENNETH CExecutive Chair · Director | Sale | −20.4K | $99.09 | $2.0M | 700.7Kdirect | Nov 3, 2022 | Nov 7, 2022 | Form 4 ↗ |
| FRAZIER KENNETH CExecutive Chair · Director | Sale | −214.6K | $98.68 | $21.2M | 721.0Kdirect | Nov 3, 2022 | Nov 7, 2022 | Form 4 ↗ |
| FRAZIER KENNETH CExecutive Chair · Director | Sale | −94.3K | $100.40 | $9.5M | 700.7Kdirect | Nov 2, 2022 | Nov 3, 2022 | Form 4 ↗ |
| FRAZIER KENNETH CExecutive Chair · Director | Sale | −205.7K | $99.68 | $20.5M | 795.0Kdirect | Nov 2, 2022 | Nov 3, 2022 | Form 4 ↗ |
| FRAZIER KENNETH CExecutive Chair · Director | Sale | −700 | $101.05 | $71K | 706.3Kdirect | Nov 1, 2022 | Nov 3, 2022 | Form 4 ↗ |
| FRAZIER KENNETH CExecutive Chair · Director | Sale | −97.0K | $100.22 | $9.7M | 707.0Kdirect | Nov 1, 2022 | Nov 3, 2022 | Form 4 ↗ |
| FRAZIER KENNETH CExecutive Chair · Director | Sale | −202.3K | $99.61 | $20.2M | 804.0Kdirect | Nov 1, 2022 | Nov 3, 2022 | Form 4 ↗ |
| FRAZIER KENNETH CExecutive Chair · Director | Sale | −229.3K | $101.03 | $23.2M | 706.3Kdirect | Oct 31, 2022 | Nov 1, 2022 | Form 4 ↗ |
| FRAZIER KENNETH CExecutive Chair · Director | Sale | −70.7K | $99.82 | $7.1M | 935.6Kdirect | Oct 31, 2022 | Nov 1, 2022 | Form 4 ↗ |
| Chattopadhyay SanatExe V-P & Pres. MMD | Sale | −100.3K | $100.10 | $10.0M | 45.6Kdirect | Oct 28, 2022 | Nov 1, 2022 | Form 4 ↗ |
| DeLuca Richard R.EVP&Pres, Merck Animal Heallth | Sale | −164.6K | $100.26 | $16.5M | 137.0Kdirect | Oct 28, 2022 | Nov 1, 2022 | Form 4 ↗ |
| FRAZIER KENNETH CExecutive Chair · Director | Sale | −178.4K | $100.80 | $18.0M | 706.3Kdirect | Oct 28, 2022 | Nov 1, 2022 | Form 4 ↗ |
| FRAZIER KENNETH CExecutive Chair · Director | Sale | −313.2K | $100.25 | $31.4M | 884.6Kdirect | Oct 28, 2022 | Nov 1, 2022 | Form 4 ↗ |
| FRAZIER KENNETH CExecutive Chair · Director | Sale | −75.5K | $99.15 | $7.5M | 1.2Mdirect | Oct 28, 2022 | Nov 1, 2022 | Form 4 ↗ |
| Karachun Rita ASr. VP Fince-Global Controller | Sale | −32.0K | $100.34 | $3.2M | 41.1Kdirect | Oct 28, 2022 | Nov 1, 2022 | Form 4 ↗ |
| MIZELL STEVENEVP, Chief HR Officer | Sale | −8,000 | $98.84 | $791K | 32.1Kdirect | Oct 28, 2022 | Nov 1, 2022 | Form 4 ↗ |
| MIZELL STEVENEVP, Chief HR Officer | Sale | −17.0K | $100.00 | $1.7M | 40.1Kdirect | Oct 28, 2022 | Nov 1, 2022 | Form 4 ↗ |
| Oosthuizen Johannes JacobusPresident, U.S. Market | Sale | −3,633 | $100.21 | $364K | 10.9Kdirect | Oct 28, 2022 | Nov 1, 2022 | Form 4 ↗ |
| Zachary JenniferEVP, General Counsel | Sale | −65.5K | $99.85 | $6.5M | 38.0Kdirect | Oct 28, 2022 | Nov 1, 2022 | Form 4 ↗ |
| Zachary JenniferEVP, General Counsel | Sale | −99.8K | $99.07 | $9.9M | 103.5Kdirect | Oct 28, 2022 | Nov 1, 2022 | Form 4 ↗ |
| FRAZIER KENNETH CExecutive Chair · Director | Sale | −29.6K | $83.23 | $2.5M | 586.8Kdirect | Nov 9, 2021 | Nov 10, 2021 | Form 4 ↗ |
| FRAZIER KENNETH CExecutive Chair · Director | Sale | −634.3K | $82.22 | $52.1M | 616.4Kdirect | Nov 9, 2021 | Nov 10, 2021 | Form 4 ↗ |
| DeLuca Richard R.EVP&Pres, Merck Animal Heallth | Sale | −29.8K | $90.40 | $2.7M | 116.9Kdirect | Nov 4, 2021 | Nov 5, 2021 | Form 4 ↗ |
| Litchfield CarolineEVP & CFO | Sale | −18.3K | $91.00 | $1.7M | 24.1Kdirect | Nov 4, 2021 | Nov 5, 2021 | Form 4 ↗ |
| Karachun Rita ASr. VP Fince-Global Controller | Sale | −25.0K | $88.45 | $2.2M | 35.8Kdirect | Nov 3, 2021 | Nov 4, 2021 | Form 4 ↗ |
| Gerberding Julie L.EVP, Chief Patient Officer | Sale | −96.3K | $87.91 | $8.5M | 39.2Kdirect | Nov 1, 2021 | Nov 3, 2021 | Form 4 ↗ |
| Clyburn FrankEVP & Pres ? Human Health | Sale | −39.8K | $87.87 | $3.5M | 97.1Kdirect | Nov 1, 2021 | Nov 2, 2021 | Form 4 ↗ |
| Chattopadhyay SanatExe V-P & Pres. MMD | Sale | −24.6K | $87.32 | $2.1M | 93.1Kdirect | Oct 29, 2021 | Nov 2, 2021 | Form 4 ↗ |
| DeLuca Richard R.EVP&Pres, Merck Animal Heallth | Sale | −135.4K | $87.56 | $11.9M | 116.9Kdirect | Oct 29, 2021 | Nov 2, 2021 | Form 4 ↗ |
| Clyburn FrankEVP & Pres ? Human Health | Sale | −19.3K | $78.32 | $1.5M | 94.3Kdirect | May 10, 2021 | May 11, 2021 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −144.9K | $81.74 | $11.8M | 411.5Kdirect | Nov 9, 2020 | Nov 12, 2020 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −135.1K | $81.08 | $11.0M | 556.4Kdirect | Nov 9, 2020 | Nov 12, 2020 | Form 4 ↗ |
| Davis Robert MEVP, Global Svcs & CFO | Sale | −251.3K | $81.03 | $20.4M | 171.1Kdirect | Oct 5, 2020 | Oct 6, 2020 | Form 4 ↗ |
| Chattopadhyay SanatExe V-P & Pres. MMD | Sale | −10.4K | $83.01 | $862K | 67.4Kdirect | Aug 13, 2020 | Aug 17, 2020 | Form 4 ↗ |
| Clyburn FrankEVP, Chief Commercial Officer | Sale | −18.9K | $81.55 | $1.5M | 80.8Kdirect | Aug 5, 2020 | Aug 6, 2020 | Form 4 ↗ |
| Gerberding Julie L.EVP Strat Comm, GI Pub Policy | Sale | −18.2K | $80.01 | $1.5M | 26.6Kdirect | Jul 17, 2020 | Jul 20, 2020 | Form 4 ↗ |
| Gerberding Julie L.EVP Strat Comm, GI Pub Policy | Sale | −18.1K | $80.00 | $1.4M | 44.8Kdirect | Jul 17, 2020 | Jul 20, 2020 | Form 4 ↗ |
| WEEKS WENDELL PDirector | Sale | −5,000 | $76.02 | $380K | 100direct | May 7, 2020 | May 7, 2020 | Form 4 ↗ |
| BRUN LESLIE ADirector | Sale | −5,000 | $75.46 | $377K | 1,948direct | May 7, 2020 | May 7, 2020 | Form 4 ↗ |
| Gerberding Julie L.EVP Strat Comm, GI Pub Policy | Sale | −102.1K | $89.34 | $9.1M | 37.0Kdirect | Jan 13, 2020 | Jan 15, 2020 | Form 4 ↗ |
| DeLuca Richard R.EVP&Pres, Merck Animal Heallth | Sale | −6,427 | $85.09 | $547K | 71.5Kdirect | Aug 9, 2019 | Aug 12, 2019 | Form 4 ↗ |
| DeLuca Richard R.EVP&Pres, Merck Animal Heallth | Sale | −31.7K | $85.01 | $2.7M | 71.5Kdirect | Aug 8, 2019 | Aug 12, 2019 | Form 4 ↗ |
| Davis Robert MEVP, Global Svcs & CFO | Sale | −26.6K | $86.00 | $2.3M | 137.7Kdirect | Jun 25, 2019 | Jun 27, 2019 | Form 4 ↗ |
| Davis Robert MEVP, Global Svcs & CFO | Sale | −190.2K | $85.35 | $16.2M | 164.2Kdirect | Jun 25, 2019 | Jun 27, 2019 | Form 4 ↗ |
| Clyburn FrankEVP, Chief Commercial Officer | Sale | −25.0K | $77.73 | $1.9M | 67.6Kdirect | May 7, 2019 | May 9, 2019 | Form 4 ↗ |
| DeLuca Richard R.EVP&Pres, Merck Animal Heallth | Sale | −35.0K | $80.00 | $2.8M | 71.1Kdirect | May 3, 2019 | May 7, 2019 | Form 4 ↗ |
| Davis Robert MEVP, Global Svcs & CFO | Sale | −192.6K | $82.38 | $15.9M | 137.7Kdirect | Mar 25, 2019 | Mar 27, 2019 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −192.7K | $82.05 | $15.8M | 797.7Kdirect | Mar 20, 2019 | Mar 20, 2019 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −18.7K | $82.00 | $1.5M | 797.7Kdirect | Mar 13, 2019 | Mar 14, 2019 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −6,961 | $82.00 | $571K | 797.7Kdirect | Mar 5, 2019 | Mar 6, 2019 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −13.1K | $82.01 | $1.1M | 797.7Kdirect | Mar 4, 2019 | Mar 6, 2019 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −54.0K | $80.02 | $4.3M | 692.0Kdirect | Feb 22, 2019 | Feb 22, 2019 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −42.0K | $80.00 | $3.4M | 692.0Kdirect | Feb 21, 2019 | Feb 22, 2019 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −42.7K | $80.02 | $3.4M | 692.0Kdirect | Feb 19, 2019 | Feb 19, 2019 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −92.9K | $80.03 | $7.4M | 692.0Kdirect | Feb 15, 2019 | Feb 19, 2019 | Form 4 ↗ |
| Karachun Rita ASr. VP Fince-Global Controller | Sale | −64.7K | $78.96 | $5.1M | 16.2Kdirect | Feb 14, 2019 | Feb 14, 2019 | Form 4 ↗ |
| WEEKS WENDELL PDirector | Sale | −5,000 | $78.71 | $394K | 100direct | Feb 13, 2019 | Feb 14, 2019 | Form 4 ↗ |
| Chattopadhyay SanatExe V-P & Pres. MMD | Sale | −73.7K | $78.62 | $5.8M | 51.5Kdirect | Feb 12, 2019 | Feb 14, 2019 | Form 4 ↗ |
| BRUN LESLIE ADirector | Sale | −3,052 | $77.22 | $236K | 1,948direct | Feb 8, 2019 | Feb 11, 2019 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −231.6K | $78.08 | $18.1M | 692.0Kdirect | Feb 5, 2019 | Feb 6, 2019 | Form 4 ↗ |
| GLOCER THOMAS HDirector | Sale | −10.0K | $75.96 | $760K | 5,100direct | Feb 4, 2019 | Feb 4, 2019 | Form 4 ↗ |
| PERLMUTTER ROGER MExe V-P & Pres, MRL | Sale | −225.4K | $75.27 | $17.0M | 141.6Kdirect | Nov 8, 2018 | Nov 8, 2018 | Form 4 ↗ |
| Gerberding Julie L.EVP Strat Comm, Gl Pub Policy | Sale | −36.2K | $75.14 | $2.7M | 46.3Kdirect | Nov 7, 2018 | Nov 8, 2018 | Form 4 ↗ |
| Schechter Adam HEVP & Pres-Global Human Health | Sale | −145.1K | $73.66 | $10.7M | 0direct | Nov 1, 2018 | Nov 2, 2018 | Form 4 ↗ |
| Schechter Adam HEVP & Pres-Global Human Health | Sale | −132.7K | $73.98 | $9.8M | 145.1Kdirect | Nov 1, 2018 | Nov 2, 2018 | Form 4 ↗ |
| Watson AshleySVP Chief Ethics & Com Officer | Sale | −47.0K | $74.33 | $3.5M | 9,770direct | Oct 31, 2018 | Nov 1, 2018 | Form 4 ↗ |
| DeLuca Richard R.EVP&Pres, Merck Animal Health | Sale | −25.5K | $72.00 | $1.8M | 56.7Kdirect | Oct 30, 2018 | Nov 1, 2018 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −279.9K | $72.07 | $20.2M | 692.0Kdirect | Oct 2, 2018 | Oct 3, 2018 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −279.9K | $70.08 | $19.6M | 692.0Kdirect | Sep 18, 2018 | Sep 19, 2018 | Form 4 ↗ |
| Schechter Adam HEVP & Pres-Global Human Health | Sale | −7,360 | $70.18 | $517K | 55.4Kindirect | Sep 17, 2018 | Sep 18, 2018 | Form 4 ↗ |
| Schechter Adam HEVP & Pres-Global Human Health | Sale | −100.0K | $70.18 | $7.0M | 0direct | Sep 17, 2018 | Sep 18, 2018 | Form 4 ↗ |
| Chattopadhyay SanatExe V-P & Pres. MMD | Sale | −29.2K | $65.20 | $1.9M | 51.5Kdirect | Aug 3, 2018 | Aug 6, 2018 | Form 4 ↗ |
| Karachun Rita ASr. VP Fince-Global Controller | Sale | −5,000 | $65.01 | $325K | 16.2Kdirect | Aug 2, 2018 | Aug 2, 2018 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −228.1K | $65.00 | $14.8M | 710.7Kdirect | Jul 31, 2018 | Aug 1, 2018 | Form 4 ↗ |
| Schechter Adam HEVP & Pres-Global Human Health | Sale | −34.1K | $61.00 | $2.1M | 62.8Kindirect | Jun 18, 2018 | Jun 19, 2018 | Form 4 ↗ |
| Schechter Adam HEVP & Pres-Global Human Health | Sale | −100.0K | $61.00 | $6.1M | 0direct | Jun 18, 2018 | Jun 19, 2018 | Form 4 ↗ |
| Gerberding Julie L.EVP Strat Comm, Gl Pub Policy | Sale | −9,972 | $59.66 | $595K | 45.7Kdirect | May 15, 2018 | May 16, 2018 | Form 4 ↗ |
| GRADDICK WEIR MIRIAN MExe V-P, HR | Sale | −24.0K | $58.00 | $1.4M | 80.4Kdirect | Apr 16, 2018 | Apr 17, 2018 | Form 4 ↗ |
| WEEKS WENDELL PDirector | Sale | −5,000 | $53.57 | $268K | 100direct | Feb 9, 2018 | Feb 9, 2018 | Form 4 ↗ |
| GRADDICK WEIR MIRIAN MExe V-P, HR | Sale Amended | −52.0K | $61.63 | $3.2M | 90.5Kdirect | Jan 16, 2018 | Jan 19, 2018 | Form 4 ↗ |
| GRADDICK WEIR MIRIAN MExe V-P, HR | Sale Amended | −8,000 | $61.63 | $493K | 142.5Kdirect | Jan 16, 2018 | Jan 19, 2018 | Form 4 ↗ |
| Schechter Adam HEVP & Pres-Global Human Health | Sale | −50.6K | $61.63 | $3.1M | 62.8Kindirect | Jan 16, 2018 | Jan 16, 2018 | Form 4 ↗ |
| Schechter Adam HEVP & Pres-Global Human Health | Sale | −51.0K | $61.63 | $3.1M | 0direct | Jan 16, 2018 | Jan 16, 2018 | Form 4 ↗ |
| Holston Michael JEVP, General Counsel | Sale | −12.5K | $61.63 | $770K | 49.1Kdirect | Jan 16, 2018 | Jan 16, 2018 | Form 4 ↗ |
| GRADDICK WEIR MIRIAN MExe V-P, HR | Sale | −52.0K | $61.63 | $3.2M | 93.5Kdirect | Jan 16, 2018 | Jan 16, 2018 | Form 4 ↗ |
| GRADDICK WEIR MIRIAN MExe V-P, HR | Sale | −8,000 | $61.63 | $493K | 145.5Kdirect | Jan 16, 2018 | Jan 16, 2018 | Form 4 ↗ |
| GRADDICK WEIR MIRIAN MExe V-P, HR | Sale Amended | −8,000 | $58.00 | $464K | 98.5Kdirect | Jan 12, 2018 | Jan 19, 2018 | Form 4 ↗ |
| GRADDICK WEIR MIRIAN MExe V-P, HR | Sale | −5,000 | $58.00 | $290K | 101.5Kdirect | Jan 12, 2018 | Jan 16, 2018 | Form 4 ↗ |
| GLOCER THOMAS HDirector | Sale | −5,000 | $56.20 | $281K | 5,100direct | Nov 8, 2017 | Nov 9, 2017 | Form 4 ↗ |
| KIDDER C ROBERTDirector | Sale | −5,000 | $63.54 | $318K | 9,317direct | May 12, 2017 | May 12, 2017 | Form 4 ↗ |
| Schechter Adam HEVP & Pres-Global Human Health | Sale | −53.9K | $63.48 | $3.4M | 116.3Kindirect | Apr 3, 2017 | Apr 4, 2017 | Form 4 ↗ |
| Karachun Rita ASr. VP Fince-Global Controller | Sale | −2,954 | $64.73 | $191K | 11.7Kdirect | Feb 14, 2017 | Feb 15, 2017 | Form 4 ↗ |
| RUSSO PATRICIA FDirector | Sale | −5,000 | $64.42 | $322K | 13.1Kdirect | Feb 8, 2017 | Feb 9, 2017 | Form 4 ↗ |
| WEEKS WENDELL PDirector | Sale | −5,000 | $64.51 | $323K | 100direct | Feb 6, 2017 | Feb 6, 2017 | Form 4 ↗ |
| WENDELL PETER CDirector | Sale | −15.0K | $63.69 | $955K | 1,000direct | Feb 3, 2017 | Feb 6, 2017 | Form 4 ↗ |
| Holston Michael JEVP, General Counsel | Sale | −78.0K | $64.00 | $5.0M | 50.3Kdirect | Feb 3, 2017 | Feb 6, 2017 | Form 4 ↗ |
| Holston Michael JEVP, General Counsel | Sale | −14.0K | $63.69 | $892K | 128.2Kdirect | Feb 3, 2017 | Feb 6, 2017 | Form 4 ↗ |
| Schechter Adam HEVP & Pres-Global Human Health | Sale | −36.3K | $63.73 | $2.3M | 0direct | Feb 3, 2017 | Feb 6, 2017 | Form 4 ↗ |
| Cech Thomas RDirector | Sale | −5,000 | $63.42 | $317K | 100direct | Feb 3, 2017 | Feb 6, 2017 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −133.9K | $65.03 | $8.7M | 508.9Kdirect | Nov 10, 2016 | Nov 10, 2016 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −6,080 | $65.00 | $395K | 508.9Kdirect | Nov 9, 2016 | Nov 10, 2016 | Form 4 ↗ |
| Gerberding Julie L.EVP Strat Comm, Gl Pub Policy | Sale | −85.5K | $60.02 | $5.1M | 39.1Kdirect | Nov 7, 2016 | Nov 8, 2016 | Form 4 ↗ |
| LAZARUS ROCHELLE BDirector | Sale | −20.0K | $59.06 | $1.2M | 4,594direct | Nov 2, 2016 | Nov 2, 2016 | Form 4 ↗ |
| WENDELL PETER CDirector | Sale | −5,000 | $59.50 | $298K | 1,000direct | Nov 2, 2016 | Nov 2, 2016 | Form 4 ↗ |
| GRADDICK WEIR MIRIAN MExe V-P, HR | Sale | −40.8K | $62.07 | $2.5M | 88.2Kdirect | Oct 3, 2016 | Oct 4, 2016 | Form 4 ↗ |
| Schechter Adam HEVP & Pres-Global Human Health | Sale | −39.2K | $62.61 | $2.5M | 0direct | Sep 1, 2016 | Sep 1, 2016 | Form 4 ↗ |
| Golestani ClarkEVP & Chief Info Officer | Sale | −3,000 | $63.03 | $189K | 14.1Kdirect | Aug 10, 2016 | Aug 10, 2016 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −233.0K | $61.54 | $14.3M | 508.9Kdirect | Aug 5, 2016 | Aug 5, 2016 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −140.0K | $62.24 | $8.7M | 741.8Kdirect | Aug 5, 2016 | Aug 5, 2016 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −19.0K | $62.08 | $1.2M | 881.8Kdirect | Aug 5, 2016 | Aug 5, 2016 | Form 4 ↗ |
| AMBROSE ADELE DSr.V-P & Chief Comuns Officer | Sale Amended | −7,000 | $57.80 | $405K | 17.9Kdirect | Aug 4, 2016 | Sep 6, 2017 | Form 4 ↗ |
| GRADDICK WEIR MIRIAN MExe V-P, HR | Sale | −36.0K | $58.00 | $2.1M | 87.2Kdirect | Jul 5, 2016 | Jul 5, 2016 | Form 4 ↗ |
| GRADDICK WEIR MIRIAN MExe V-P, HR | Sale | −9,000 | $57.92 | $521K | 123.2Kdirect | Jul 5, 2016 | Jul 5, 2016 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −27.6K | $58.00 | $1.6M | 522.5Kdirect | Jul 5, 2016 | Jul 5, 2016 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −32.4K | $58.00 | $1.9M | 522.5Kdirect | Jul 1, 2016 | Jul 5, 2016 | Form 4 ↗ |
| Schechter Adam HEVP & Pres-Global Human Health | Sale | −50.0K | $57.69 | $2.9M | 0direct | Jul 1, 2016 | Jul 1, 2016 | Form 4 ↗ |
| GRADDICK WEIR MIRIAN MExe V-P, HR | Sale | −30.0K | $57.49 | $1.7M | 132.2Kdirect | Jul 1, 2016 | Jul 1, 2016 | Form 4 ↗ |
| Golestani ClarkEVP & Chief Info Officer | Sale | −38.6K | $54.80 | $2.1M | 17.1Kdirect | May 20, 2016 | May 20, 2016 | Form 4 ↗ |
| Golestani ClarkEVP & Chief Info Officer | Sale | −1,230 | $54.55 | $67K | 17.1Kdirect | May 19, 2016 | May 20, 2016 | Form 4 ↗ |
| Holston Michael JEVP, General Counsel | Sale | −100.0K | $54.50 | $5.5M | 64.3Kdirect | May 10, 2016 | May 12, 2016 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −131.0K | $56.11 | $7.4M | 522.5Kdirect | Apr 14, 2016 | Apr 14, 2016 | Form 4 ↗ |
| WEEKS WENDELL PDirector | Sale | −5,000 | $55.53 | $278K | 100direct | Nov 4, 2015 | Nov 4, 2015 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −18.7K | $54.69 | $1.0M | 438.2Kdirect | Oct 29, 2015 | Oct 30, 2015 | Form 4 ↗ |
| AMBROSE ADELE DSr.V-P & Chief Comuns Officer | Sale | −37.3K | $55.08 | $2.1M | 19.7Kdirect | Oct 29, 2015 | Oct 29, 2015 | Form 4 ↗ |
| WENDELL PETER CDirector | Sale | −5,000 | $54.85 | $274K | 1,000direct | Oct 28, 2015 | Oct 28, 2015 | Form 4 ↗ |
| Golestani ClarkEVP & Chief Info Officer | Sale | −30.1K | $59.09 | $1.8M | 12.2Kdirect | Jul 31, 2015 | Aug 4, 2015 | Form 4 ↗ |
| Golestani ClarkEVP & Chief Info Officer | Sale | −912 | $58.98 | $54K | 42.2Kdirect | Jul 31, 2015 | Aug 4, 2015 | Form 4 ↗ |
| Golestani ClarkEVP & Chief Info Officer | Sale | −838 | $58.98 | $49K | 43.1Kdirect | Jul 31, 2015 | Aug 4, 2015 | Form 4 ↗ |
| Golestani ClarkEVP & Chief Info Officer | Sale | −16 | $58.98 | $944 | 44.0Kdirect | Jul 31, 2015 | Aug 4, 2015 | Form 4 ↗ |
| Schechter Adam HEVP & Pres-Global Human Health | Sale | −10.6K | $60.44 | $643K | 0direct | May 11, 2015 | May 11, 2015 | Form 4 ↗ |
| Gerberding Julie L.EVP Strat Comm, Gl Pub Policy | Sale | −38.4K | $60.99 | $2.3M | 32.0Kdirect | May 8, 2015 | May 11, 2015 | Form 4 ↗ |
| Kuhlik Bruce NExe V-P & Gen Counsel | Sale | −56.1K | $60.20 | $3.4M | 150.4Kdirect | May 4, 2015 | May 5, 2015 | Form 4 ↗ |
| Holston Michael JEVP, Legal | Sale | −95.6K | $59.84 | $5.7M | 40.0Kdirect | Apr 29, 2015 | Apr 29, 2015 | Form 4 ↗ |
| Kuhlik Bruce NExe V-P & Gen Counsel | Sale | −91.6K | $60.00 | $5.5M | 144.8Kdirect | Apr 29, 2015 | Apr 29, 2015 | Form 4 ↗ |
| Kuhlik Bruce NExe V-P & Gen Counsel | Sale | −65.3K | $59.58 | $3.9M | 236.4Kdirect | Apr 29, 2015 | Apr 29, 2015 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −5,164 | $58.67 | $303K | 353.4Kdirect | Feb 18, 2015 | Feb 18, 2015 | Form 4 ↗ |
| Deese Willie AExe V-P & Pres. MMD | Sale | −135.9K | $58.56 | $8.0M | 106.2Kdirect | Feb 11, 2015 | Feb 11, 2015 | Form 4 ↗ |
| WENDELL PETER CDirector | Sale | −5,000 | $58.76 | $294K | 1,000direct | Feb 9, 2015 | Feb 9, 2015 | Form 4 ↗ |
| Schechter Adam HEVP & Pres-Global Human Health | Sale | −74.2K | $62.48 | $4.6M | 0direct | Jan 15, 2015 | Jan 15, 2015 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −8,840 | $62.47 | $552K | 351.5Kdirect | Jan 9, 2015 | Jan 9, 2015 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −9,846 | $60.00 | $591K | 347.4Kdirect | Dec 10, 2014 | Dec 10, 2014 | Form 4 ↗ |
| Kuhlik Bruce NExe V-P & Gen Counsel | Sale | −50.0K | $62.00 | $3.1M | 128.5Kdirect | Dec 8, 2014 | Dec 8, 2014 | Form 4 ↗ |
| LAZARUS ROCHELLE BDirector | Sale | −10.0K | $59.63 | $596K | 4,595direct | Nov 26, 2014 | Nov 26, 2014 | Form 4 ↗ |
| WEEKS WENDELL PDirector | Sale | −3,200 | $59.13 | $189K | 100direct | Nov 24, 2014 | Nov 25, 2014 | Form 4 ↗ |
| WEEKS WENDELL PDirector | Sale | −1,800 | $59.13 | $106K | 3,300direct | Nov 24, 2014 | Nov 25, 2014 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −10.0K | $57.98 | $580K | 344.4Kdirect | Nov 10, 2014 | Nov 10, 2014 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −9,895 | $59.73 | $591K | 341.5Kdirect | Oct 10, 2014 | Oct 14, 2014 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −9,814 | $60.48 | $594K | 338.6Kdirect | Sep 10, 2014 | Sep 10, 2014 | Form 4 ↗ |
| Schechter Adam HEVP & Pres-Global Human Health | Sale | −22.0K | $59.70 | $1.3M | 70.8Kindirect | Aug 25, 2014 | Aug 25, 2014 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −10.1K | $57.00 | $573K | 335.5Kdirect | Aug 11, 2014 | Aug 12, 2014 | Form 4 ↗ |
| AMBROSE ADELE DSr.V-P & Chief Comuns Officer | Sale | −28.7K | $56.64 | $1.6M | 14.2Kdirect | Aug 4, 2014 | Aug 5, 2014 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −9,987 | $58.03 | $580K | 341.5Kdirect | Jul 10, 2014 | Jul 10, 2014 | Form 4 ↗ |
| GRADDICK WEIR MIRIAN MExe V-P, HR | Sale Amended | −179.7K | $59.16 | $10.6M | 93.6Kdirect | Jul 7, 2014 | Jul 22, 2014 | Form 4 ↗ |
| GRADDICK WEIR MIRIAN MExe V-P, HR | Sale Amended | −300 | $59.64 | $18K | 273.3Kdirect | Jul 7, 2014 | Jul 22, 2014 | Form 4 ↗ |
| GRADDICK WEIR MIRIAN MExe V-P, HR | Sale | −180.0K | $59.16 | $10.7M | 93.6Kdirect | Jul 7, 2014 | Jul 8, 2014 | Form 4 ↗ |
| Deese Willie AExe V-P & Pres. MMD | Sale | −72.3K | $58.26 | $4.2M | 106.2Kdirect | Jun 27, 2014 | Jun 30, 2014 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −9,985 | $58.06 | $580K | 338.6Kdirect | Jun 10, 2014 | Jun 11, 2014 | Form 4 ↗ |
| Schechter Adam HEVP & Pres-Global Human Health | Sale | −10.5K | $55.91 | $589K | 0direct | May 14, 2014 | May 14, 2014 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −10.2K | $55.00 | $562K | 335.7Kdirect | May 9, 2014 | May 13, 2014 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −6,706 | $57.14 | $383K | 310.5Kdirect | Apr 10, 2014 | Apr 11, 2014 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −3,341 | $57.44 | $192K | 317.2Kdirect | Apr 10, 2014 | Apr 11, 2014 | Form 4 ↗ |
| Kuhlik Bruce NExe V-P & Gen Counsel | Sale | −86.4K | $56.38 | $4.9M | 121.8Kdirect | Apr 4, 2014 | Apr 4, 2014 | Form 4 ↗ |
| Kuhlik Bruce NExe V-P & Gen Counsel | Sale | −58.8K | $56.50 | $3.3M | 208.2Kdirect | Apr 4, 2014 | Apr 4, 2014 | Form 4 ↗ |
| Golestani ClarkEVP & Chief Info Officer | Sale | −4,800 | $55.47 | $266K | 6,046direct | Feb 14, 2014 | Feb 14, 2014 | Form 4 ↗ |
| Golestani ClarkEVP & Chief Info Officer | Sale | −1,190 | $55.47 | $66K | 10.8Kdirect | Feb 14, 2014 | Feb 14, 2014 | Form 4 ↗ |
| Heller Bridgette PExe.VP & Pres.Con.Hlth.Care | Sale | −43.9K | $55.04 | $2.4M | 27.6Kdirect | Feb 13, 2014 | Feb 14, 2014 | Form 4 ↗ |
| Schechter Adam HEVP & Pres-Global Human Health | Sale | −18.0K | $55.61 | $1.0M | 0direct | Feb 11, 2014 | Feb 13, 2014 | Form 4 ↗ |
| FRAZIER KENNETH CChairman, President & CEO · Director | Sale | −41.5K | $54.52 | $2.3M | 262.8Kdirect | Feb 11, 2014 | Feb 11, 2014 | Form 4 ↗ |
| Canan JohnSr.V-P Finc-Global Controller | Sale | −10.0K | $55.70 | $557K | 10.7Kdirect | Feb 11, 2014 | Feb 11, 2014 | Form 4 ↗ |
| Deese Willie AExe V-P & Pres. MMD | Sale | −50.0K | $54.68 | $2.7M | 106.0Kdirect | Feb 10, 2014 | Feb 11, 2014 | Form 4 ↗ |
| WENDELL PETER CDirector | Sale | −5,000 | $54.44 | $272K | 1,000direct | Feb 10, 2014 | Feb 11, 2014 | Form 4 ↗ |
| WEEKS WENDELL PDirector | Sale | −5,000 | $54.26 | $271K | 100direct | Feb 10, 2014 | Feb 11, 2014 | Form 4 ↗ |
| Cech Thomas RDirector | Sale | −500 | $45.13 | $23K | 100direct | Oct 31, 2013 | Nov 1, 2013 | Form 4 ↗ |
| Deese Willie AExe V-P & Pres. MMD | Sale | −50.6K | $48.55 | $2.5M | 106.0Kdirect | Aug 7, 2013 | Aug 7, 2013 | Form 4 ↗ |
| AMBROSE ADELE DSr.V-P & Chief Comuns Officer | Sale | −34.2K | $46.66 | $1.6M | 13.8Kdirect | May 15, 2013 | May 16, 2013 | Form 4 ↗ |
| Heller Bridgette PExe.VP & Pres.Con.Hlth.Care | Sale | −5,404 | $46.15 | $249K | 21.7Kdirect | May 13, 2013 | May 15, 2013 | Form 4 ↗ |
| Heller Bridgette PExe.VP & Pres.Con.Hlth.Care | Sale | −54.5K | $45.08 | $2.5M | 27.1Kdirect | May 7, 2013 | May 8, 2013 | Form 4 ↗ |
| Kuhlik Bruce NExe V-P & Gen Counsel | Sale | −250.0K | $45.05 | $11.3M | 92.4Kdirect | May 6, 2013 | May 8, 2013 | Form 4 ↗ |
| Deese Willie AExe V-P & Pres. MMD | Sale | −36.2K | $45.20 | $1.6M | 98.0Kdirect | May 6, 2013 | May 8, 2013 | Form 4 ↗ |
| Kuhlik Bruce NExe V-P & Gen Counsel | Sale | −61.4K | $44.02 | $2.7M | 77.8Kdirect | Nov 12, 2012 | Nov 13, 2012 | Form 4 ↗ |
| Schechter Adam HEVP & Pres-Global Human Health | Sale | −56.3K | $45.60 | $2.6M | 14.9Kdirect | Nov 5, 2012 | Nov 6, 2012 | Form 4 ↗ |
| KIM PETER SExe V-P & Pres, MRL | Sale | −420.0K | $45.50 | $19.1M | 170.7Kdirect | Nov 5, 2012 | Nov 6, 2012 | Form 4 ↗ |
| Deese Willie AExe V-P & Pres. MMD | Sale | −31.1K | $44.26 | $1.4M | 88.4Kdirect | Aug 9, 2012 | Aug 10, 2012 | Form 4 ↗ |
| Deese Willie AExe V-P & Pres. MMD | Sale | −17.2K | $44.25 | $762K | 119.5Kdirect | Aug 9, 2012 | Aug 10, 2012 | Form 4 ↗ |
| Deese Willie AExe V-P & Pres. MMD | Sale | −5,700 | $44.26 | $252K | 136.7Kdirect | Aug 9, 2012 | Aug 10, 2012 | Form 4 ↗ |
| Deese Willie AExe V-P & Pres. MMD | Sale | −4,500 | $44.27 | $199K | 142.4Kdirect | Aug 9, 2012 | Aug 10, 2012 | Form 4 ↗ |
| Deese Willie AExe V-P & Pres. MMD | Sale | −3,300 | $44.24 | $146K | 146.9Kdirect | Aug 9, 2012 | Aug 10, 2012 | Form 4 ↗ |
| Deese Willie AExe V-P & Pres. MMD | Sale | −300 | $44.28 | $13K | 150.2Kdirect | Aug 9, 2012 | Aug 10, 2012 | Form 4 ↗ |
| Deese Willie AExe V-P & Pres. MMD | Sale | −200 | $44.27 | $9K | 150.5Kdirect | Aug 9, 2012 | Aug 10, 2012 | Form 4 ↗ |
| Canan JohnSr.V-P Finc-Global Controller | Sale | −30.5K | $44.29 | $1.4M | 5,058direct | Aug 1, 2012 | Aug 2, 2012 | Form 4 ↗ |
| Bowles Richard S IIIExe VP&Chief Ethics & ComplOff | Sale | −27.4K | $38.50 | $1.1M | 73.5Kdirect | May 10, 2012 | May 10, 2012 | Form 4 ↗ |
| Bowles Richard S IIIExe VP&Chief Ethics & ComplOff | Sale | −15.8K | $38.77 | $613K | 73.5Kdirect | Feb 17, 2012 | Feb 21, 2012 | Form 4 ↗ |
| Bowles Richard S IIIExe VP&Chief Ethics & ComplOff | Sale | −7,030 | $38.78 | $273K | 89.3Kdirect | Feb 17, 2012 | Feb 21, 2012 | Form 4 ↗ |
| Bowles Richard S IIIExe VP&Chief Ethics & ComplOff | Sale | −6,677 | $38.79 | $259K | 96.4Kdirect | Feb 17, 2012 | Feb 21, 2012 | Form 4 ↗ |
| Bowles Richard S IIIExe VP&Chief Ethics & ComplOff | Sale | −4,700 | $38.76 | $182K | 103.0Kdirect | Feb 17, 2012 | Feb 21, 2012 | Form 4 ↗ |
| Bowles Richard S IIIExe VP&Chief Ethics & ComplOff | Sale | −4,700 | $38.81 | $182K | 107.7Kdirect | Feb 17, 2012 | Feb 21, 2012 | Form 4 ↗ |
| Bowles Richard S IIIExe VP&Chief Ethics & ComplOff | Sale | −1,100 | $38.80 | $43K | 112.4Kdirect | Feb 17, 2012 | Feb 21, 2012 | Form 4 ↗ |
| Bowles Richard S IIIExe VP&Chief Ethics & ComplOff | Sale | −755 | $38.79 | $29K | 113.5Kdirect | Feb 17, 2012 | Feb 21, 2012 | Form 4 ↗ |
| Bowles Richard S IIIExe VP&Chief Ethics & ComplOff | Sale | −300 | $38.78 | $12K | 114.3Kdirect | Feb 17, 2012 | Feb 21, 2012 | Form 4 ↗ |
| Bowles Richard S IIIExe VP&Chief Ethics & ComplOff | Sale | −234 | $38.82 | $9K | 114.6Kdirect | Feb 17, 2012 | Feb 21, 2012 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →